马德里格尔制药 MDGL
$399.63 −$0.47 (-0.12%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $403.28 +0.91%
开盘$400.00
昨收$400.10
当日区间$378.28 – $401.61
成交量1.09M
市值$9.28B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$364.25M+71.2% YoY
营业利润-$56.31M-19.3% YoY
净利润-$57.94M-37.0% YoY
摊薄每股收益-$1.99-32.7% YoY
自由现金流$19.08M+140.5% YoY
经营现金流$23.33M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率91.5%
营业利润率-25.1%
净利率-25.3%
净资产收益率-53.3%
资产收益率-28.8%
投入资本回报率-38.9%
流动比率3.20
负债/资产比率57.9%
现金及投资$838.75M
总负债$346.72M
净现金（净负债）$492.04M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $364.25M | $311.34M | $958.40M | $321.08M | $287.27M |
| 营业总收入 | $364.25M | $311.34M | $958.40M | $321.08M | $287.27M |
| 营业成本 | $40.01M | $26.85M | $56.15M | $24.45M | $18.12M |
| 毛利润 | $324.25M | $284.49M | $902.26M | $296.64M | $269.15M |
| 营业费用 | $380.55M | $377.21M | $1.20B | $356.24M | $383.12M |
| 销售及管理费用 | $289.38M | $268.52M | $813.83M | $239.98M | $209.12M |
| -管理费用 | $289.38M | – | – | – | $209.12M |
| 研发费用 | $91.18M | $108.69M | $388.53M | $116.27M | $174.00M |
| 营业利润 | -$56.31M | -$92.72M | -$300.10M | -$59.61M | -$113.98M |
| 非经营性利息净收入（支出） | -$836,000.00 | $424,000.00 | $15.06M | $1.16M | $2.86M |
| 非经营性利息收入 | $7.10M | $8.24M | $37.36M | $9.46M | $10.31M |
| 非经营性利息支出 | $7.94M | $7.82M | $22.31M | $8.30M | $7.45M |
| 其他收入（支出） | -$795,000.00 | -$2.09M | -$3.24M | -$128,000.00 | -$3.07M |
| 其他非经营性收入（支出） | -$795,000.00 | -$2.09M | -$463,000.00 | -$128,000.00 | -$293,000.00 |
| 税前利润 | -$57.94M | -$94.39M | -$288.28M | -$58.58M | -$114.19M |
| 净利润 | -$57.94M | -$94.39M | -$288.28M | -$58.58M | -$114.19M |
| 持续经营利润 | -$57.94M | -$94.39M | -$288.28M | -$58.58M | -$114.19M |
| 归属母公司净利润 | -$57.94M | -$94.39M | -$288.28M | -$58.58M | -$114.19M |
| 归属普通股股东净利润 | -$57.94M | -$94.39M | -$288.28M | -$58.58M | -$114.19M |
| 基本每股收益 | -$1.99 | -$3.25 | -$12.85 | -$2.57 | -$5.08 |
| 摊薄每股收益 | -$1.99 | -$3.25 | -$12.85 | -$2.57 | -$5.08 |
| 特殊收益（费用） | – | – | -$2.78M | $0.00 | -$2.78M |
| -减：其他特殊支出 | – | – | $2.78M | $0.00 | $2.78M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.24B | $1.23B | $1.26B | $1.26B | $1.36B |
| 流动资产合计 | $1.20B | $1.18B | $1.25B | $1.25B | $1.35B |
| 现金及现金等价物与短期投资 | $838.75M | $812.77M | $983.56M | $983.56M | $1.11B |
| -现金及现金等价物 | $292.73M | $227.03M | $198.69M | $198.69M | $295.69M |
| -短期投资 | $546.03M | $585.74M | $784.87M | $784.87M | $814.06M |
| 应收款 | $192.31M | $187.36M | $134.48M | $134.48M | $113.29M |
| -应收账款 | $192.31M | $187.36M | $134.48M | $134.48M | $113.29M |
| 存货 | $99.39M | $112.07M | $74.84M | $74.84M | $69.32M |
| 受限现金 | $155,000.00 | $5.16M | $5.09M | $5.09M | $5.00M |
| 其他流动资产 | $68.57M | $64.96M | $47.80M | $47.80M | $49.33M |
| 非流动资产合计 | $45.47M | $45.02M | $13.82M | $13.82M | $15.78M |
| 固定资产净值 | $17.17M | $14.24M | $6.44M | $6.44M | $8.30M |
| -固定资产原值 | $17.17M | $14.24M | $6.44M | $6.44M | $8.30M |
| 商誉及其他无形资产 | $7.19M | $7.28M | $7.38M | $7.38M | $7.48M |
| 其他非流动资产 | $21.11M | $23.50M | – | – | – |
| 负债合计 | $720.92M | $683.87M | $656.90M | $656.90M | $736.73M |
| 流动负债合计 | $374.20M | $338.26M | $310.29M | $310.29M | $391.41M |
| 应付款 | $34.51M | $60.80M | $48.88M | $48.88M | $44.94M |
| -应付账款 | $34.51M | $60.80M | $48.88M | $48.88M | $44.94M |
| 一年内应计费用 | $292.53M | $241.43M | $191.18M | $191.18M | $294.27M |
| 短期债务及融资租赁负债 | $1.03M | $1.70M | $1.02M | $1.02M | $1.08M |
| -一年内到期融资租赁负债 | $1.03M | $1.70M | $1.02M | $1.02M | $1.08M |
| 非流动负债合计 | $346.72M | $345.61M | $346.61M | $346.61M | $345.32M |
| 长期债务及融资租赁负债 | $346.72M | $345.61M | $346.61M | $346.61M | $345.32M |
| -长期债务 | $340.79M | $340.33M | $339.88M | $339.88M | $339.75M |
| -长期融资租赁负债 | $5.92M | $5.28M | $6.73M | $6.73M | $5.57M |
| 股东权益合计 | $523.72M | $543.45M | $602.69M | $602.69M | $625.73M |
| 股东权益 | $523.72M | $543.45M | $602.69M | $602.69M | $625.73M |
| 股本 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -普通股 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.77B | $2.73B | $2.69B | $2.69B | $2.66B |
| 留存收益 | -$2.24B | -$2.18B | -$2.09B | -$2.09B | -$2.03B |
| 不影响留存收益的损益 | $808,000.00 | $1.08M | $873,000.00 | $873,000.00 | $1.07M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $23.33M | -$167.44M | -$189.55M | -$133.46M | $79.85M |
| 持续经营经营活动现金流净额 | $23.33M | -$167.44M | -$189.55M | -$133.46M | $79.85M |
| 持续经营净利润 | -$57.94M | -$94.39M | -$288.28M | -$58.58M | -$114.19M |
| 折旧、折耗与摊销 | $381,000.00 | $386,000.00 | $1.51M | $392,000.00 | $358,000.00 |
| 其他非现金项目 | $1.04M | -$1.58M | $4.81M | $1.40M | $1.55M |
| 营运资金变动 | $33.42M | -$105.87M | -$8.50M | -$102.47M | $163.10M |
| -应收款变动 | -$4.96M | -$52.88M | -$80.65M | -$21.19M | -$34.05M |
| -存货变动 | -$11.46M | -$22.19M | -$36.98M | -$1.73M | -$5.82M |
| -预付资产变动 | -$1.23M | -$40.65M | -$34.02M | $1.53M | $9.28M |
| -应付账款及应计费用变动 | $51.04M | $9.85M | $143.15M | -$81.07M | $193.70M |
| 投资活动现金流净额 | $34.20M | $192.19M | $32.32M | $27.58M | -$207.00M |
| 持续经营投资活动现金流净额 | $34.20M | $192.19M | $32.32M | $27.58M | -$207.00M |
| 固定资产购置及出售净额 | -$4.25M | -$3.85M | -$467,000.00 | $390,000.00 | -$857,000.00 |
| 投资购置及出售净额 | $38.45M | $196.04M | $35.79M | $27.19M | -$203.14M |
| 筹资活动现金流 | $3.11M | $2.33M | $255.98M | $8.96M | $236.65M |
| 持续经营筹资活动现金流净额 | $3.11M | $2.33M | $255.98M | $8.96M | $236.65M |
| 期末现金余额 | $292.88M | $232.19M | $203.78M | $203.78M | $300.69M |
| 现金净变动 | $60.64M | $27.09M | $98.75M | -$96.92M | $109.50M |
| 期初现金余额 | $232.19M | $203.78M | $105.02M | $300.69M | $191.19M |
| 汇率变动影响 | $57,000.00 | $1.32M | $13,000.00 | – | – |
| 自由现金流 | $19.08M | -$171.28M | -$193.02M | -$133.07M | $75.99M |
| 普通股发行净额 | – | $2.33M | $0.00 | $0.00 | – |
| 持续经营损益 | – | – | $2.78M | $0.00 | – |
| 无形资产购置及出售净额 | – | – | -$3.00M | $0.00 | – |
| 债务发行及偿还净额 | – | – | $228.34M | $0.00 | – |
| 股票期权行使所得 | – | – | $38.06M | $9.94M | $17.74M |
| 其他筹资费用净额 | – | – | -$10.41M | -$983,000.00 | – |
暂无评论——快来第一个聊聊 MDGL。